Return to Headlines
435 views
Email RSS

Relatively Low Performance Detected in Shares of NxStage Medical in the Healthcare Sector (NXTM, QGEN, VVUS, AZN, SYK)

Written on Mon, 07/26/2010 - 10:53am
By Chip Brian

Below are the top five companies in the Healthcare sector as measured by relative performance. Lowest relative performance is a comparison between a share and its peers made to determine under performance.
This analysis was based on yesterday's trading activity as SmarTrend searches for stocks that could be relative bargains compared to their peers.
NxStage Medical (NASDAQ:NXTM) ranks first with a loss of 1.58%; QIAGEN (NASDAQ:QGEN) ranks second with a loss of 1.47%; and Vivus (NASDAQ:VVUS) ranks third with a loss of 1.39%.
AstraZeneca (NYSE:AZN) follows with a loss of 0.68% and Stryker (NYSE:SYK) rounds out the top five with a loss of 0.56%.
SmarTrend is bullish on shares of NXTM and our subscribers were alerted to Buy on May 27, 2010 at $13.90. The stock has risen 20.7% since the alert was issued.

Contact Chip Brian
Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.